A new botanical ingredient called Koncentra is launching globally, aiming to offer energy, focus, and mood enhancement without caffeine. The ingredient comes from a partnership between dsm-firmenich and Nous, an Italian startup that specializes in functional food ingredients.
The caffeine-free formula was developed after screening various botanicals. Active components include ashwagandha, ginkgo biloba, holy basil, and oats. Koncentra’s production uses a proprietary extraction technology that the manufacturer says preserves the natural bioactive compounds while keeping the process consistent and scalable.
It is being positioned as an alternative to traditional energy drinks and supplements. The goal is to provide sustained performance without the side effects often linked to caffeine, such as jitters, anxiety, and energy crashes.
While caffeine still dominates the energy market, dsm-firmenich notes that consumer preferences are changing. More people are aware of caffeine’s drawbacks and are looking for balanced, natural alternatives. They want solutions that support long-term energy by addressing the biological foundations of cognitive performance rather than relying on short-term stimulants.
“The demand for science-backed, balanced energy solutions is growing rapidly, and Koncentra is a highly promising innovation that aligns with the shift toward caffeine-free energy solutions,” said Ingrid Damen, director of Global Business Development and Beverages at dsm-firmenich.
For the people most affected by this — athletes, professionals, and anyone who relies on mental clarity throughout the day — the appeal is straightforward. Caffeine works, but it often comes with a cost. A product that delivers focus and energy without the crash could change how people manage their daily routines, especially for those who are sensitive to stimulants or need to avoid them for health reasons.
Related: Indonesia Community Pharmacies Role
dsm-firmenich recently invested in Nous through its ventures activities. The company plans to support Koncentra’s further development, including claims substantiation and market validation. This will help move the ingredient from clinical development into commercial use within the energy category.
Specifically, dsm-firmenich will help design clinical trials to back up Koncentra’s claims about energy and cognitive performance. The firm brings consumer insights, application expertise, and regulatory knowledge to the table, which should help refine product concepts and ensure the ingredient is ready for customer applications.
Koncentra is designed to be soluble in powder form and uses a low effective dose. According to the report, this allows for “seamless integration” into various foods and beverages with little impact on taste, color, or turbidity.
“Today’s energy solutions are still largely built around caffeine, which often comes with trade-offs that consumers are increasingly unwilling to accept. We see a clear opportunity to redefine the category by moving toward more balanced solutions,” said Lorenzo Pessini, CEO and founder of Nous.
“Koncentra represents a new generation of botanical ingredients, designed to deliver sustained energy alongside focus and mood support without overstimulation,” Pessini added. He said the collaboration with dsm-firmenich is a key step in bringing that vision to scale.
Koncentra is entering a market that already has competitors. Beneo has highlighted the energy benefits of its Palatinose ingredient for athletes on low-glycemic diets. Nektium offers Zynamite, a mango leaf extract backed by nine human clinical trials that the company says boosts reaction time and concentration through a different mechanism than caffeine. Ethical Naturals recently launched MachaWave, which blends organic matcha with L-theanine to balance energy with calm focus. The shift away from caffeine also relates to broader conversations about nutrition training needed beyond medical school as consumers seek more holistic health approaches.
